The medical industry
report “Bioreactor Market
Size By Cell (Mammalian Cells, Bacterial Cells, Yeast Cells, Others), By
Molecule (Monoclonal Antibodies, Vaccines, Recombinant Proteins, Stem Cells,
Gene Therapy, Others), By Technology (Wave-Induced Motion SUB, Stirred SUB,
Single Use Bubble Column, Other SUB), By End-Use ( R&D organizations,
Biopharma Manufacturers, CMOs) Industry Analysis Report, Regional Outlook
(U.S., Canada, Germany, UK, Spain, Italy, France, Netherland, Denmark, China,
Japan, India, South Korea, Australia, Singapore, Brazil, Mexico, UAE, South
Africa), Application Development, Price Trend, Competitive Landscape &
Forecast, 2017 – 2024”, by Global Market
Insights, Inc. says,
the Global Bioreactor Industry is estimated to register 18% CAGR over the
period of 2016-2024.
Growing
focus on R&D in biotechnology and increasingly rising chronic disorders are
outlined as the prime drivers behind bioreactors market growth. The investments
in the biopharmaceutical sector are soaring as demand for product innovation,
and effective therapeutic vaccines are on a constant rise. Besides, favorable
government initiatives to expand and improve healthcare infrastructure will
further provide an impetus to bioreactors market. The surging precision
medicine market has impelled personalized medical treatments for the patients,
which, in turn, will favor the growth of bioreactor industry.
Progressing tissue engineering
technologies, development of orphan drugs, and growing antibodies production
are also identified as the typical trends which are significantly driving the
bioreactors market share. Biopharma manufacturers, CMOs (Contract manufacturing
organizations) and R&D organizations are the three predominant end-use
industries in the worldwide bioreactor market. Holding more than 30% of overall
bioreactor industry share in 2016, biopharmaceutical manufacturers have enabled
effective drug delivery systems and combination products. The bioreactor
industry is likely to spectate growing collaborations in biopharmaceutical
sector through strategic partnerships with diagnostic developers, medical
device manufacturers, and even academic institutions.
One such example is of Sartorius Stedim
Biotech, a leading global supplier in the biopharmaceutical industry
acquisition of U.S. start-up kSep Holdings, Inc. in 2016. kSep Systems leverages its innovation and
engineering expertise to develop automated centrifugation systems which are
widely used in manufacturing of monoclonal antibodies, cell-based therapeutics,
and vaccines. This USD 28 million deal successfully expanded Sartorius’
bioprocessing solutions portfolio.
The growing number of pharmaceutical companies and
technological advancements in the medical space is driving the U.S. bioreactor
market size, slated to cross an industry valuation of USD 600 million by 2024.
Germany bioreactor market accounted for more than 25% of Europe share and is
anticipated to grow substantially over the years ahead, with the presence of
leading industry players, favorable governmental policies, and rising
healthcare expenditures.
Based on technology, bioreactor market is segmented into
single use bubble column, wave-induced motion SUB, and stirred SUB technology.
Accounting for more than one half of the global bioreactor industry share, the
wave-induced motion SUB technology represents the biggest technological
segment. Stirred SUBs is also set to accelerate its business with its growing
demand in biopharmaceutical industry. Stirred SUBs market is anticipated to
record more than 18% CAGR over the period of 2016-2024.
China bioreactor industry driven by rising prevalence
of chronic diseases and increasing R&D investment in the region is further
expected to record an annual growth rate of 19% over the time span of
2016-2024. An overall shift from traditional methods to new production
techniques of monoclonal antibodies, cell culturing, and recombinant proteins
will keep Asia Pacific bioreactor market growth perpetual.
The monoclonal antibodies occupied over 35% of the
overall industry share by collecting revenue worth USD 190 million in 2016.
Increasing application of the monoclonal antibodies molecule in the treatment
of asthma, leukemia, breast cancers, etc. have attributed to the segment’s
growth.
Taking into account the bioreactor market bifurcation
based on type of cells, mammalian cells held over 75% of industry share.
Furthermore, the yeast cells demand is projected to record a CAGR of 15% over
the period of 2016-2024. Increasing research activities is likely to expand the
business for bioreactors.
Eppendorf, Sartorius, GE Healthcare, Thermo Fisher
Scientific, and Merck Millipore are some of the prominent players in bioreactor
industry.
Browse Related Reports:
Precision Medicine Market Size By
Technology (Big Data Analytics, Gene Sequencing, Drug Discovery,
Bioinformatics, Companion Diagnostics), By Application (Oncology, CNS,
Immunology, Respiratory), Industry Analysis Report, Regional Outlook (U.S.,
Canada, Germany, UK, France, Scandinavia, Italy, Japan, China, India,
Singapore, Mexico, Brazil, South Africa, UAE, Qatar, Saudi Arabia), Application
Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2023
About Global Market Insights:
Global
Market Insights, Inc., headquartered in Delaware, U.S., is a global market
research and consulting service provider; offering syndicated and custom
research reports along with growth consulting services. Our business
intelligence and industry research reports offer clients with penetrative
insights and actionable market data specially designed and presented to aid
strategic decision making. These exhaustive reports are designed via a
proprietary research methodology and are available for key industries such as
chemicals, advanced materials, technology, renewable energy and biotechnology.
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Web: https://www.gminsights.com
Blog: https://gminsights.wordpress.com
Connect with us: Facebook | Google+ | LinkedIn | Twitter
Your blog provided us with valuable information to work with. Thanks a lot for sharing. Keep blogging. Management Consulting Services in Bangalore | Pharmaceutical Consulting Services in Bangalore | Market Research Companies in Bangalore
ReplyDelete